The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Choline phospholipid metabolism: A target in cancer cells?
Abstract
The experience of treating cancer over the past several decades overwhelmingly demonstrates that the disease continues to evade the vast array of drugs and treatment modalities available in the twenty‐first century. This is not surprising in view of the complexity of this disease, and the multiplicities of pathways available to the cancer cell to enable its survival. Although the progression of cancer arrives at a common end point of cachexia, organ failure, and death, common pathways are rare in cancer. Identifying and targeting common pathways that would act across these levels of multiplicity is essential for the successful treatment of this disease. Over the past decade, one common characteristic consistently revealed by magnetic resonance spectroscopic studies is the elevation of phosphocholine and total choline‐containing compounds in cancer cells and solid tumors. This elevation has been observed in almost every single cancer type studied with NMR spectroscopy and can be used as an endogenous biomarker of cancer. In this article, we have summarized some of the observations on the choline phospholipid metabolism of cancer cells and tumors, and make a case for targeting the aberrant choline phospholipid metabolism of cancer cells. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Studies of human tumors by MRS: A review
Negendank, W. (1992) · NMR in Biomedicine · doi:10.1002/nbm.1940050518 · Cited by 660
Aboagye, E. O., & Bhujwalla, Z. M. (1999) · PubMed · Cited by 596
Self-citationTumour phospholipid metabolism
Podo, F. (1999) · NMR in Biomedicine · doi:10.1002/(sici)1099-1492(199911)12:7<413::aid-nbm587>3.0.co;2-u · Cited by 579
Biochemistry of Lipids, Lipoproteins and Membranes
Spector, A. A. (1992) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(92)90069-2 · Cited by 408
Ramı́rez de Molina, A., Rodrı́guez-González, A., Gutiérrez, R., Martı́nez-Piñeiro, L., Sánchez, J. J., Bonilla, F., Rosell, R., & Lacal, J. C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00920-8 · Cited by 340
Ackerstaff, E., Pflug, B. R., Nelson, J. B., & Bhujwalla, Z. M. (2001) · PubMed · Cited by 285
Self-citationRamírez de Molina, A., Gutiérrez, R., Ramos, M. A., Silva, J. M., Silva, J., Bonilla, F., Sánchez, J. J., & Lacal, J. C. (2002) · Oncogene · doi:10.1038/sj.onc.1205556 · Cited by 257
Rozic, J. G., Chakraborty, C., & Lala, P. K. (2001) · International Journal of Cancer · doi:10.1002/ijc.1376 · Cited by 233
Katz‐Brull, R., & Degani, H. (1996) · PubMed · Cited by 169
Overexpression of phospholipase D1 in human breast cancer tissues
Noh, D. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00612-1 · Cited by 166
Prostaglandins, their inhibitors and cancer
LUPULESCU, A. P. (1996) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90064-2 · Cited by 150
Yamashita, S.-I., Yamashita, J.-I., & Ogawa, M. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.229 · Cited by 147
Oncogenic potential of erbB-2 in human mammary epithelial cells.
Pierce, J. H., Arnstein, P., DIMARCO, E., Artrip, J., Mh, K., Lonardo, F., Fiore, D., & Aaronson, S. A. (1991) · PubMed · Cited by 140
Cai, H., Erhardt, P., Troppmair, J., Díaz-Meco, M. T., Sithanandam, G., Rapp, U. R., Moscat, J., & Cooper, G. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7645 · Cited by 138
Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy.
Gribbestad, I. S., Sitter, B., Lundgren, S., Krane, J., & Axelson, D. E. (1999) · PubMed · Cited by 121
Hernández-Alcoceba, R., Fernández, F., & Lacal, J. C. (1999) · PubMed · Cited by 118
Bhujwalla, Z. M., Aboagye, E. O., Gillies, R. J., Chacko, V. P., Mendola, C. E., & Backer, J. M. (1999) · Magnetic Resonance in Medicine · Cited by 93
Self-citationZhong, M., Shen, Y., Yang, Z., Joseph, T. W., Jackson, D. N., & Foster, D. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00229-8 · Cited by 91
Pathologic Characterization of Human Prostate Tissue with Proton MR Spectroscopy
Swindle, P., McCredie, S., Russell, P., Himmelreich, U., Khadra, M. H., Lean, C. L., & Mountford, C. E. (2003) · Radiology · doi:10.1148/radiol.2281011808 · Cited by 91
Phospholipases in biology and medicine
Kaiser, E., Chiba, P., & Zaky, K. (1990) · Clinical Biochemistry · doi:10.1016/0009-9120(90)90051-u · Cited by 76
Ronen, S. M., Jackson, L. E., Beloueche‐Babari, M., & Leach, M. O. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1663 · Cited by 76
TNF-induced modulations of phospholipid metabolism in human breast cancer cells
Bogin, L., Papa, M. Z., Polak‐Charcon, S., & Degani, H. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00035-6 · Cited by 41
Lacal, J. C. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)80913-7 · Cited by 37
Phospholipases A2 in ras-transformed and immortalized human mammary epithelial cells
Guthridge, C. J., Stampfer, M. R., Clark, M. A., & Steiner, M. R. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90175-9 · Cited by 23
Mori, N., Natarajan, K., Chacko, V. P., Artemov, D., & Bhujwalla, Z. M. (2003) · Molecular Imaging · doi:10.1162/15353500200303127 · Cited by 16
Self-citation
Cited by
Sugimoto, M., Wong, D. T., Hirayama, A., Soga, T., & Tomita, M. (2010) · Metabolomics · doi:10.1007/s11306-009-0178-y · Cited by 993
Clinical Applications of Metabolomics in Oncology: A Review
Spratlin, J. L., Serkova, N. J., & Eckhardt, S. G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1059 · Cited by 753
Stork, C., & Renshaw, P. F. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001711 · Cited by 477
Quehenberger, O., & Dennis, E. A. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1104901 · Cited by 454
Keshari, K. R., & Wilson, D. M. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60124b · Cited by 358
Metadata
- Authors
- Ackerstaff, E., Glunde, K., & Bhujwalla, Z. M.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2003-09-19
- Volume
- 90
- Issue
- 3
- Pages
- 525-533
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2035935275
- Cited by
- 315
- References
- 26
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.